Chemoinformaics analysis of 4,4-DIMETHYLTETRACYCLO[6.3.2.01,8.02,5]TRIDECAN-9-OL
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 34 |
| Exact Molecular Weight | 220.183 | nRing | 4 |
| Solubility: LogS | -2.016 | nHRing | 0 |
| Solubility: LogP | 1.632 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.063 |
| Synth | 4.515 |
| Natural Product Likeliness | 0.752 |
| NR-PPAR-gamma | 0.541 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.215 |
| Pgp-sub | 0 |
| HIA | 0.997 |
| CACO-2 | -7.085 |
| MDCK | 0.00000931 |
| BBB | 0.004 |
| PPB | 0.835412 |
| VDSS | 0.39 |
| FU | 0.238084 |
| CYP1A2-inh | 0.293 |
| CYP1A2-sub | 0.008 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.016 |
| CYP2c9-inh | 0.371 |
| CYP2c9-sub | 0.018 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.071 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.004 |
| CL | 13.877 |
| T12 | 0.985 |
| hERG | 0.077 |
| Ames | 0.047 |
| ROA | 0 |
| SkinSen | 0.968 |
| Carcinogencity | 0.007 |
| EI | 0.934 |
| Respiratory | 0.001 |
| NR-Aromatase | 0.482 |
| Antiviral | Yes |
| Prediction | 0.864709 |